We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About TRex Bio Stock

Invest in or calculate the value of your shares in TRex Bio or other pre-IPO companies through EquityZen's platform.

Get Started

TRex Bio Stock (TRXB)

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

About TRex Bio Stock

Founded

2018

Headquarters

South San Francisco, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

TRexBio is a discovery stage biotechnology company leveraging cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us to identify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis.

TRex Bio Management

Leadership team at TRex Bio

CEO

Johnston Erwin

Chief Medical Officer

Ovid Trifan

Locked Features

Join now and verify your accreditation status to gain access to:

  • TRex Bio Current Valuation
  • TRex Bio Stock Price
  • TRex Bio Management
  • Available deals in TRex Bio and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • TRex Bio Cap Table and Funding History by Share Class and Liquidity Preferences
    • TRex Bio Revenue and Financials
    • TRex Bio Highlights
    • TRex Bio Business Model
    • TRex Bio Risk Factors
  • TRex Bio Research Report from SACRA Research
Join Now

Trading TRex Bio Stock

How to invest in TRex Bio stock?

Accredited investors can buy pre-IPO stock in companies like TRex Bio through EquityZen funds. These investments are made available by existing TRex Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell TRex Bio stock?

Shareholders can sell their TRex Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."